Dogs vaccinated with common lyme disease vaccines do not respond to IR 6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 458-462

  O'Connor, Thomas P ^a   Esty, Kathy J ^a   Hanscom, Jancy L ^a   Shields, Paulette ^a   Philipp, Mario T ^b  

^a IDEXX LABORATORIES   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; C6 PEPTIDE; ENZYME; GALAXY LYME; LYME DISEASE VACCINE; LYMEVAX; MEMBRANE PROTEIN; METHIONYLLYSYLLYSYLASPARTYLASPARTYLGLUTAMINYLISOLEUCYLALANYLALANYLALANYLMET HIONYLVALYLLEUCYLARGINYLGLYCYLMETHIONYLALANYLLYSYLASPARTYLGLYCYLGLUTAMINYLPHENYL ALANYLALANYLLEUCYLLYSINE; POLYPEPTIDE; PROTEIN VLSE; RECOMBITEK LYME; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONSERVED IMMUNODOMINANT REGION; CONTROLLED STUDY; DOG; IMMUNOFLUORESCENCE TEST; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SERODIAGNOSIS; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOTTING, WESTERN; BORRELIA BURGDORFERI; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOASSAY; IMMUNODOMINANT EPITOPES; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MALE; PEPTIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION;

EID: 2442683013     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.458-462.2004     Document Type: Article

References (18)

1. Barony, G., and R. B. Merrifield. 1980. The peptides: analysis, synthesis, & biology. Academic Press, Inc., New York, N.Y.
2. Barthold, S. W., S. A. Levy, E. Fikrig, L. K. Bockenstedt, and A. L. Smith. 1995. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J. Am. Vet. Med. Assoc. 207:1435-1440.
3. Gauthier, D. T., and L. S. Mansfield. 1999. Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs. J. Vet. Diagn. Investig. 11:259-265.
4. Guerra, M. A., E. D. Walker, and U. Kitron. 2000. Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure. J. Clin. Microbiol. 38:2628-2632.
5. Hashida, S., M. Imagawa, S. Inoue, K. H. Ruan, and E. Ishikawa. 1984. More useful maleimide compounds for the conjugation of Fab′ to horseradish peroxidase through the thiol groups in the hinge. J. Appl. Biochem. 6:56-63.
6. Jacobson, R. H., Y. F. Chang, and S. J. Shin. 1996. Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs. Semin. Vet. Med. Surg. (Small Anim.) 11:172-182.
7. Lawrenz, M. B., J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere, G. P. Wormser, and S. J. Norris. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
8. 6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet. Ther. 3:308-315.
9. Liang, F. T., and M. T. Philipp. 1999. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect. Immun. 67:6702-6706.
10. Liang, F. T., and M. T. Philipp. 2000. Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect. Immun. 68:2349-2352.
11. Liang, F. T., E. Aberer, M. Cinco, L. Gern, C. M. Hu, Y. N. Lobet, M. Ruscio, P. E. Voet, Jr., V. E. Weynants, and M. T. Philipp. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182:1455-1462.
12. Liang, F. T., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. 1999. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol. 163:5566-5573.
13. Liang, F. T., L. C. Bowers, and M. T. Philipp. 2001. C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect. Immun. 69:3224-3231.
14. Liang, F. T., R. H. Jacobson, R. K. Straubinger, A. Grooters, and M. T. Philipp. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38:4160-4166.
15. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
16. 6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
17. Purser, J. E., and S. J. Norris. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 97:13865-13870.
18. Sheets, J. T., C. A. Rossi, B. J. Kearney, and G. E. Moore. 2000. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of Borrelia burgdorferi exposure in dogs. J. Am. Vet. Med. Assoc. 216:1418-1422.